Life Science Ventures Vii L.p. Tvm, 10% Owner at CoLucid Pharmaceuticals, Inc. (CLCD), bought 1,495,386 shares at $10.00 ($5.0M) on 2015-05-11, disclosed to the SEC on 2015-05-12.
Open-market purchase of $5.0M CLCD by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 995,386 | $0 | 0.0% |
| 2 | $10.00 | 500,000 | $5.0M | 100.0% |
| Total | $3.34 avg | 1,495,386 | $5.0M | 100% |